Literature DB >> 16105473

Lipoprotein(a): implications for clinical practice.

Robert C Block1, Thomas A Pearson.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16105473     DOI： 10.1007/s11883-005-0041-1

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  25 in total

1.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

Authors:  K BERG
Journal:  Acta Pathol Microbiol Scand       Date:  1963

2.  Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans.

Authors:  S M Marcovina; J J Albers; E Wijsman; Z Zhang; N H Chapman; H Kennedy
Journal:  J Lipid Res       Date:  1996-12       Impact factor: 5.922

3.  High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.

Authors:  F Paultre; T A Pearson; H F Weil; C H Tuck; M Myerson; J Rubin; C K Francis; H F Marx; E F Philbin; R G Reed; L Berglund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

4.  Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid.

Authors:  L A Carlson; A Hamsten; A Asplund
Journal:  J Intern Med       Date:  1989-10       Impact factor: 8.989

5.  Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia.

Authors:  M Seed; F Hoppichler; D Reaveley; S McCarthy; G R Thompson; E Boerwinkle; G Utermann
Journal:  N Engl J Med       Date:  1990-05-24       Impact factor: 91.245

6.  Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins.

Authors:  Allen J Taylor; Lance E Sullenberger; Hyun J Lee; Jeannie K Lee; Karen A Grace
Journal:  Circulation       Date:  2004-11-10       Impact factor: 29.690

7.  Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies.

Authors:  W Y Craig; L M Neveux; G E Palomaki; M M Cleveland; J E Haddow
Journal:  Clin Chem       Date:  1998-11       Impact factor: 8.327

Review 8.  Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside.

Authors:  Santica M Marcovina; Marlys L Koschinsky
Journal:  Curr Opin Lipidol       Date:  2003-08       Impact factor: 4.776

9.  Familial lipoprotein disorders in patients with premature coronary artery disease.

Authors:  J J Genest; S S Martin-Munley; J R McNamara; J M Ordovas; J Jenner; R H Myers; S R Silberman; P W Wilson; D N Salem; E J Schaefer
Journal:  Circulation       Date:  1992-06       Impact factor: 29.690

10.  Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study.

Authors:  Nader Rifai; Jing Ma; Frank M Sacks; Paul M Ridker; Wendy Jade L Hernandez; Meir J Stampfer; Santica M Marcovina
Journal:  Clin Chem       Date:  2004-05-20       Impact factor: 8.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.